Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,398,285
+$1,423,324 QoQ
Shares Held
45,296
-1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#861
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Van Hulzen Asset Management, LLC holds $51,223,577 across 8 Drug Manufacturers - General names. ABBV ranks #2 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
118,886 | $30,193,477 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
45,296 | $11,398,285 | |
| 3 | LLY |
ELI LILLY & Co
|
2,080 | $2,494,814 | |
| 4 | AMGN |
Amgen Inc
|
6,577 | $2,381,663 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,759 | $1,768,031 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,160 | $1,030,934 | |
| 7 | PFE |
Pfizer Inc
|
40,772 | $981,789 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,914 | $974,584 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,398,285 | 45,296 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,974,961 | 45,864 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,384,185 | 45,447 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $10,315,570 | 44,552 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,166,166 | 43,994 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,962,846 | 42,778 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $30,097,759 | 169,374 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $32,860,672 | 166,400 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $35,270,343 | 205,634 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $35,117,256 | 192,846 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $30,425,105 | 196,329 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $29,940,638 | 200,863 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $27,100,535 | 201,147 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $31,438,123 | 197,265 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $25,261,420 | 156,311 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $19,856,906 | 147,954 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $26,882,490 | 175,519 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $30,569,244 | 188,571 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $25,035,866 | 184,903 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $12,094,276 | 112,119 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,578,734 | 111,672 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $11,631,485 | 107,480 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $12,172,882 | 113,606 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,565,018 | 120,619 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $12,780,286 | 130,172 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $10,740,885 | 140,975 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||